Publications by authors named "Mathias Berndt"

Claim this Profile
V
Value of Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study.
Mohsen Beheshti, Pekka Taimen, Jukka Kemppainen, Ivan Jambor, Andre Müller, Mathias Berndt

Eur Radiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FSPG PET/CT Imaging of System x Transporter Activity in Patients with Primary and Metastatic Brain Tumors.
Mirwais Wardak, Ida Sonni, Audrey P Fan, Ryogo Minamimoto, Mehran Jamali, Mathias Berndt

Radiology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x in tumors.
Hannah E Greenwood, Richard Edwards, Norman Koglin, Mathias Berndt, Friedrich Baark

Theranostics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core.
Heiko Kroth, Felix Oden, Andreia Monica Serra, Jerome Molette, Andre Mueller, Mathias Berndt

Bioorg Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other Tauopathies.
Heiko Kroth, Felix Oden, Jerome Molette, Hanno Schieferstein, Emanuele Gabellieri, Mathias Berndt

J Med Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GMP-Compliant Radiosynthesis of [F]GP1, a Novel PET Tracer for the Detection of Thrombi.
Verena Hugenberg, Marion Zerna, Mathias Berndt, Reinhard Zabel, Rainer Preuss

Pharmaceuticals (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [Ga]Ga-RM2.
Adrien Chastel, Delphine Vimont, Stephane Claverol, Marion Zerna, Sacha Bodin, Mathias Berndt

Pharmaceutics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.
Matthias M Herth, Simon Ametamey, Dmitrii Antuganov, Andreas Bauman, Mathias Berndt

Nucl Med Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Evaluation of (4S)-4-(3-[F]Fluoropropyl)-L-glutamate (F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer.
Sonya Youngju Park, Sae Jung Na, Meena Kumar, Camila Mosci, Mirwais Wardak, Mathias Berndt

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies.
Emanuele Gabellieri, Francesca Capotosti, Jerome Molette, Nampally Sreenivasachary, Andre Mueller, Mathias Berndt

Eur J Med Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial evaluation of (4S)-4-(3-[F]fluoropropyl)-L-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma.
Sonya Y Park, Camila Mosci, Meena Kumar, Mirwais Wardak, Norman Koglin, Mathias Berndt

EJNMMI Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau PET imaging with F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study.
Andre Mueller, Santiago Bullich, Olivier Barret, Jennifer Madonia, Mathias Berndt

J Nucl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain.
Santiago Bullich, Olivier Barret, Cristian Constantinescu, Christine Sandiego, Andre Mueller, Mathias Berndt

J Nucl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dosimetry of [F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolism.
Narae Lee, Inhye Oh, Sun Young Chae, Soyoung Jin, Seung Jun Oh, Mathias Berndt

Nucl Med Biol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Characterization of F-hGTS13 for Molecular Imaging of x Transporter Activity with PET.
Corinne Beinat, Gayatri Gowrishankar, Bin Shen, Israt S Alam, Elise Robinson, Mathias Berndt

J Nucl Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical characterization of [F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies.
Heiko Kroth, Felix Oden, Jerome Molette, Hanno Schieferstein, Francesca Capotosti, Mathias Berndt

Eur J Nucl Med Mol Imaging· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Tumor Redox Status through ()-4-(3-[F]fluoropropyl)-L-Glutamic Acid PET Imaging of System x Activity.
Patrick N McCormick, Hannah E Greenwood, Matthias Glaser, Oliver D K Maddocks, Thibault Gendron, Mathias Berndt

Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, first-in-human study of F-GP1 positron emission tomography for imaging acute arterial thrombosis.
Sun Young Chae, Tae-Won Kwon, Soyoung Jin, Sun U Kwon, Changhwan Sung, Mathias Berndt

EJNMMI Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoprotein IIb/IIIa receptor imaging with F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study.
Chanwoo Kim, Jae Seung Lee, Youngjin Han, Sun Young Chae, Soyoung Jin, Mathias Berndt

J Nucl Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
Jessica Lohrke, Holger Siebeneicher, Markus Berger, Michael Reinhardt, Mathias Berndt

J Nucl Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Erik S Mittra, Norman Koglin, Camila Mosci, Meena Kumar, Aileen Hoehne, Mathias Berndt

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
Michelle T Fodero-Tavoletti, Damian Brockschnieder, Victor L Villemagne, Lucas Martin, Andrea R Connor, Mathias Berndt

Nucl Med Biol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism.
Norman Koglin, Andre Mueller, Mathias Berndt, Heribert Schmitt-Willich, Luisella Toschi

Clin Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-[18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization.
Raisa N Krasikova, Olga F Kuznetsova, Olga S Fedorova, Yuri N Belokon, Viktor I Maleev, Mathias Berndt

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct labelling of peptides with 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG).
Frank Wuest, Christina Hultsch, Mathias Berndt, Ralf Bergmann

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis